The once thriving blank-check market is now grappling with persistent accounting dilemmas. According to a story by Bloomberg Tax, the latest issue disturbing the market includes figuring out how to account for certain types of backup funding arrangements utilized by special purpose acquisition companies (SPACs).
SPACs employ these arrangements to ensure that transactions to take companies public proceed as planned, even if investors withdraw their participation. Recent examples show that three companies that became public through SPAC merger in the past month – Envoy Medical Inc., Electriq Power Holdings Inc., and Ocean Biomedical Inc. – have highlighted accounting mistakes that were serious enough to necessitate restating their prior fiscal reports.
This report highlights from the Securities and Exchange Commission (SEC), a recommendation for SPACs to consult with the agency about so-called backstop funding arrangements as these financing deals have been tripping up shell companies. These errors underscore the fact that SPACs remain a challenging area from a regulatory standpoint, fraught with complex accounting considerations and requiring significant scrutiny and oversight.
The course of action these companies will take to rectify these errors and how these missteps will affect future SPAC deals remains to be seen. This development is a cautionary tale for both existing SPACs and potential market entrants to sufficiently comprehend the accounting rules and regulations governing these transactions.
Legal professionals should be cognizant of these developments given the increasing prevalence of SPACs as a go-public strategy and the potential legal and regulatory ramifications of accounting mishaps.